Jordyn Feingold

Jordyn Feingold

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Chronic Stress
Verified
Journal Article
Open access
PDF file
JFJordyn Feingold
Jordyn Feingold
LPLauren Peccoralo
Lauren Peccoralo
CCChi C. Chan
Chi C. Chan
CKCarly A. Kaplan
Carly A. Kaplan
HKHalley Kaye-Kauderer
Halley Kaye-Kauderer
JRJonathan Ripp
Jonathan Ripp
Background: This study sought to assess the magnitude of and factors associated with mental health outcomes among frontline health care workers (FHCWs) providing care during the Spring 2020 COVID-19 pandemic surge in New York City. Methods: A cross-sectional, survey-based study over 4 weeks during the Spring 2020 pandemic surge was used to assess symptoms of COVID-19-related posttraumatic stress disorder (PTSD), major depressive disorder (MDD), and generalized anxiety disorder (GAD) in 2,579 FHCWs at the Mount Sinai Hospital. Participants were additionally asked about their occupational and personal exposures to COVID-19. Multivariable logistic regression and relative importance analyses were conducted to identify factors associated with these outcomes. Results: A total of 3,360 of 6,026 individuals completed the survey (55.8% participation), with 2,579 (76.8%) analyzed based on endorsing frontline responsibilities and providing information related to the three outcomes. 1,005 (39.0%) met criteria for symptoms of COVID-19-related PTSD, MDD, or GAD. 599 (23.3%) screened positively for PTSD symptoms, 683 (26.6%) for MDD symptoms, and 642 (25.0%) for GAD symptoms. Multivariable analyses revealed that past-year burnout was associated with the highest risk of developing symptoms for COVID-19-related PTSD (odds ratio [OR] = 2.10), MDD (OR = 2.83), and GAD (OR = 2.68). Higher perceived support from hospital leadership was associated with a lowest risk of all outcomes [PTSD (OR = 0.75), MDD (OR = 0.72), and GAD (OR = 0.76). Conclusion: In this large sample of FHCWs providing care during the 2020 NYC pandemic surge, 39% experienced symptoms of COVID-19-related PTSD, MDD, and/or GAD and pre-pandemic burnout as well as leadership support were identified as the most highly associated factors. These findings suggest that interventions aimed at reducing burnout and augmenting support from hospital leadership may be appropriate targets to mitigate the risk for developing further psychopathology in this population and others working in the midst of crisis.

16 September 2021 in Journal of Affective Disorders
Verified
Journal Article
Closed access
JFJordyn Feingold
Jordyn Feingold
AHAlicia Hurtado
Alicia Hurtado
AFAdriana Feder
Adriana Feder
LPLauren Peccoralo
Lauren Peccoralo
SSSteven M. Southwick
Steven M. Southwick
RPRobert H. Pietrzak
Robert H. Pietrzak

1 December 2017 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
CWCharlene A. Wong
Charlene A. Wong
VMVictoria A. Miller
Victoria A. Miller
KMKathryn Murphy
Kathryn Murphy
DSDylan Small
Dylan Small
CFCarol A. Ford
Carol A. Ford
MPMitesh S. Patel
Mitesh S. Patel
Glycemic control in type 1 diabetes often deteriorates during adolescence and the transition to young adulthood with increased risks of acute and long-term complications.1,2 This poor control is attributed to difficulties with adhering to the prescribed medical regimen.2-4 These challenges occur in the context of decreasing parental involvement and developing psychosocial maturity.5-7 As young people prepare to transition to adult models of care that require independent self-management skills, interventions that empower them to successfully manage chronic disease can improve outcomes.6

23 January 2021 in Neurogastroenterology & Motility
Verified
Journal Article
Open access
PDF file
JFJordyn Feingold
Jordyn Feingold
DDDouglas A. Drossman
Douglas A. Drossman
Stigma, defined as social devaluation based on negative stereotypes toward a particular population, is prevalent within health care and is a common phenomenon in disorders of gut‐brain interaction (DGBI). Characteristically, DGBI including functional dyspepsia (FD) lack a structural etiology to explain symptoms, have high psychiatric co‐morbidity, and respond to neuromodulators traditionally used to treat psychopathology. As a result, these disorders are frequently and wrongly presumed to be psychiatric and carry a great deal of stigma. Stigma has profound adverse consequences for patients, including emotional distress, medication non‐adherence, barriers to accessing care, and increased symptoms. The basis for stigma dates back to the 17th Century concept of mind‐body dualism. Patients and health care providers need to understand the factors that promote stigma and methods to ameliorate it. In this minireview, we address the data presented in Yan et al.'s (Neurogastroenterol Motil, 2020, e13956). We offer concrete solutions for clinicians to mitigate the impact of stigma to optimize treatment adherence and clinical outcomes for patients with DGBI.

1 November 2014 in Schizophrenia Research
Verified
Journal Article
Closed access
KCKristina Cieslak
Kristina Cieslak
JFJordyn Feingold
Jordyn Feingold
DADaniel Antonius
Daniel Antonius
JWJulie Walsh-Messinger
Julie Walsh-Messinger
RDRoberta Dracxler
Roberta Dracxler
DMDolores Malaspina
Dolores Malaspina

1 November 2017 in Gastroenterology
Verified
Journal Article
Open access
PDF file
SMShivan J. Mehta
Shivan J. Mehta
JFJordyn Feingold
Jordyn Feingold
MVMatthew Vandertuyn
Matthew Vandertuyn
TNTess Niewood
Tess Niewood
CCCatherine Cox
Catherine Cox
DADavid A. Asch
David A. Asch
Behavioral economic approaches could increase uptake for colorectal cancer screening. We performed a randomized controlled trial of 2245 employees to determine whether an email containing a phone number for scheduling (control), an email with the active choice to opt in or opt out (active choice), or the active choice email plus a $100 incentive (financial incentive) increased colonoscopy completion within 3 months. Higher proportions of participants in the financial incentive group underwent screening (3.7%) than in the control (1.6%) or active choice groups (1.5%) (P = .01 and P < .01). We found no difference in uptake of screening between the active choice and control groups (P = .88). The $100 conditional incentive modestly but significantly increased colonoscopy use. ClinicalTrials.gov no: NCT02660671.